The European Medicines Agency
has released a draft policy on the
publication and access to clinical
trial data for a three-month public
consultation.
The Agency has defined three
categories of clinical-trial data
corresponding to different levels of
access:
• Cat 1:“Commercially Confidential”
• Cat 2: “Open Access”
• Cat 3: “Controlled Access”
The draft policy has now been
released for a three-month public
consultation.
Publication of the final policy is
expected by the end of 2013, with
implementation from 01 Jan 2014.
For further details CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 25 Jun 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Jun 13
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.